Citadel Advisors LLC 13D and 13G filings for Coherus Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:58 pm Sale | 2023-12-31 | 13G | Coherus Oncology, Inc. CHRS | Citadel Advisors LLC | 2,047,286 1.800% | -3,767,788 (-64.79%) | Filing |
| 2023-05-19 09:15 am Purchase | 2023-05-18 | 13G | Coherus Oncology, Inc. CHRS | Citadel Advisors LLC | 5,815,074 6.200% | 5,815,074 (New Position) | Filing |